ProShares UltraShort Nasdaq Biotechnology (BIS)
BIS is a passive ETF by ProShares tracking the investment results of the NASDAQ Biotechnology Index (-200%). BIS launched on Apr 7, 2010 and has a 0.95% expense ratio.
ETF Info
| ISIN | US74347B7890 |
|---|---|
| CUSIP | 74347G838 |
| Issuer | ProShares |
| Inception Date | Apr 7, 2010 |
| Region | North America (U.S.) |
| Category | Leveraged Equities, Leveraged |
| Leveraged | 2x |
| Index Tracked | NASDAQ Biotechnology Index (-200%) |
| Home Page | www.proshares.com |
| Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Growth |
Expense Ratio
The ProShares UltraShort Nasdaq Biotechnology has a high expense ratio of 0.95%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: BIS vs. BIB, BIS vs. IBBQ, BIS vs. RSPN, BIS vs. XLV
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in ProShares UltraShort Nasdaq Biotechnology, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
ProShares UltraShort Nasdaq Biotechnology had a return of 17.13% year-to-date (YTD) and 12.92% in the last 12 months. Over the past 10 years, ProShares UltraShort Nasdaq Biotechnology had an annualized return of -24.73%, while the S&P 500 had an annualized return of 10.37%, indicating that ProShares UltraShort Nasdaq Biotechnology did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 17.13% | 5.06% |
| 1 month | 16.87% | -3.23% |
| 6 months | -11.46% | 17.14% |
| 1 year | 12.92% | 20.62% |
| 5 years (annualized) | -22.06% | 11.54% |
| 10 years (annualized) | -24.73% | 10.37% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -0.45% | -1.80% | 0.40% | |||||||||
| 2023 | 8.96% | 14.73% | -9.45% | -21.67% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
ProShares UltraShort Nasdaq Biotechnology(BIS)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
ProShares UltraShort Nasdaq Biotechnology granted a 2.26% dividend yield in the last twelve months. The annual payout for that period amounted to $0.47 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|
| Dividend | $0.47 | $0.32 | $0.00 | $0.00 | $0.10 | $1.13 | $0.34 |
Dividend yield | 2.26% | 1.75% | 0.00% | 0.00% | 0.44% | 2.11% | 0.37% |
Monthly Dividends
The table displays the monthly dividend distributions for ProShares UltraShort Nasdaq Biotechnology. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.16 | |||||||||
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.18 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2020 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2019 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.32 | $0.00 | $0.00 | $0.17 |
| 2018 | $0.07 | $0.00 | $0.00 | $0.27 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the ProShares UltraShort Nasdaq Biotechnology. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the ProShares UltraShort Nasdaq Biotechnology was 99.76%, occurring on Sep 2, 2021. The portfolio has not yet recovered.
The current ProShares UltraShort Nasdaq Biotechnology drawdown is 99.67%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.76% | Jul 7, 2010 | 2717 | Sep 2, 2021 | — | — | — |
| -13.04% | Jun 10, 2010 | 3 | Jun 15, 2010 | 9 | Jul 1, 2010 | 12 |
| -11.83% | May 7, 2010 | 4 | May 12, 2010 | 5 | May 20, 2010 | 9 |
| -9.45% | May 27, 2010 | 4 | Jun 3, 2010 | 2 | Jun 8, 2010 | 6 |
| -6.59% | Apr 28, 2010 | 2 | Apr 29, 2010 | 4 | May 5, 2010 | 6 |
Volatility
Volatility Chart
The current ProShares UltraShort Nasdaq Biotechnology volatility is 8.99%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.